Joel Tillinghast is back from a three-month sabbatical, but, in his absence, his six co-managers ran the fund like he was never gone.
Take heed of these seven personal finance tips now and have no regrets about your early financial life later.
Fidelity Select Biotechnology and Fidelity Advisor Biotechnology contain a mix of the tried-and-true and the speculative.
Oakmark International's David Herro has the record to back up his bullish stance on big, multinational companies.
You don't have to give up performance to invest with your conscience.
You don't have to sell right away, but you'll do better with Ginnie Maes and junk bonds with short maturities.
Investing editors Manny Schiffres and Nellie Huang will be online on Thursday, April 26, from 12:30 p.m. to 1:30 p.m. ET to answer your questions about our favorite no-load mutual funds.
As expected, this Kiplinger 25 fund outperforms in down markets, lags in weak markets. A rise in deal activity could boost returns.
Reach your investment goals with these plans using our favorite no-load mutual funds.
This fund's performance has been impressive, but its manager's silence makes it hard to recommend.
Outsize three-year mutual fund returns are no longer dragged down by the 2008 stock market crash.
This year’s picks for the Kiplinger 25 include new ways to generate income.
This Kiplinger 25 fund aims first to minimize losses, and only then tries to earn money for shareholders.
Be a DIY investor with stocks, bonds, funds and ETFs.
Follow these steps to find the right professional for you.